Choice of the adequate quantification method for recombinant human GM-CSF produced in different host systems
Full Text
Reprint PDF

Keywords

bioassay
ELISA
GM-CSF
monoclonal antibody
quantification

How to Cite

1.
Bollati Fogolín M, Oggero Eberhardt M, Kratje R, Etcheverrigaray M. Choice of the adequate quantification method for recombinant human GM-CSF produced in different host systems. Electron. J. Biotechnol. [Internet]. 2002 Dec. 15 [cited 2024 Nov. 23];5(3):0-. Available from: https://www.ejbiotechnology.info/index.php/ejbiotechnology/article/view/v5n3-6

Abstract

Three enzyme-linked-immunosorbent assays (ELISA) were developed and compared with a bioassay to quantify the recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF). These assays were suitable to quantify the non-glycosylated rhGM-CSF present in mixtures with variable protein content, and therefore useful for determining concentrations of the cytokine in production processes. Among these assays, the competitive ELISA, developed with a MAb that recognises an epitope not involved in glycosylation, was the only one suitable to quantify the glycosylated form of rhGM-CSF produced in mammalian cell cultures.

Full Text
Reprint PDF

Upon acceptance of an article by the journal, authors will be asked to transfer the copyright to Electronic Journal of Biotechnology, which is committed to maintain the electronic access to the journal and to administer a policy of fair control and ensure the widest possible dissemination of the information. The author can use the article for academic purposes, stating clearly the following: "Published in Electronic Journal of Biotechnology at DOI:10.2225/volXX-issueX-fulltext-XX".

The Copyright Transfer Agreement must be submitted as a signed scanned copy to biotec@ucv.cl. All authors must send a copy of this document.